These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 17435162

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Design of potent and selective agonists for the human vasopressin V1b receptor based on modifications of [deamino-cys1]arginine vasopressin at position 4.
    Cheng LL, Stoev S, Manning M, Derick S, Pena A, Mimoun MB, Guillon G.
    J Med Chem; 2004 Apr 22; 47(9):2375-88. PubMed ID: 15084136
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Mapping the binding site of six nonpeptide antagonists to the human V2-renal vasopressin receptor.
    Macion-Dazard R, Callahan N, Xu Z, Wu N, Thibonnier M, Shoham M.
    J Pharmacol Exp Ther; 2006 Feb 22; 316(2):564-71. PubMed ID: 16234409
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Position 4 analogues of [deamino-Cys(1)] arginine vasopressin exhibit striking species differences for human and rat V(2)/V(1b) receptor selectivity.
    Guillon G, Pena A, Murat B, Derick S, Trueba M, Ventura MA, Szeto HH, Wo N, Stoev S, Cheng LL, Manning M.
    J Pept Sci; 2006 Mar 22; 12(3):190-8. PubMed ID: 16130178
    [Abstract] [Full Text] [Related]

  • 12. Identification of novel selective V2 receptor non-peptide agonists.
    Del Tredici AL, Vanover KE, Knapp AE, Bertozzi SM, Nash NR, Burstein ES, Lameh J, Currier EA, Davis RE, Brann MR, Mohell N, Olsson R, Piu F.
    Biochem Pharmacol; 2008 Oct 30; 76(9):1134-41. PubMed ID: 18761325
    [Abstract] [Full Text] [Related]

  • 13. Pharmacological characterization of RWJ-676070, a dual vasopressin V(1A)/V(2) receptor antagonist.
    Gunnet JW, Wines P, Xiang M, Rybczynski P, Andrade-Gordon P, de Garavilla L, Parry TJ, Cheung WM, Minor L, Demarest KT, Maryanoff BE, Damiano BP.
    Eur J Pharmacol; 2008 Aug 20; 590(1-3):333-42. PubMed ID: 18599033
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. In vitro and in vivo pharmacological characterisation of the potent and selective vasopressin V(1A) receptor antagonist 4-[4-(4-Chloro-phenyl)-5-[1,2,3]triazol-2-ylmethyl-4H-[1,2,4]triazol-3-yl]-piperidin-1-yl-(3,5-difluoro-phenyl) methanone (PF-00738245).
    Russell R, Doyle R, Turner J, Attkins N, Ramsey S, Weibley L, Bateman L, Bictash M, Neal-Morgan S, Ivarsson M, Pullen N.
    Eur J Pharmacol; 2011 Nov 30; 670(2-3):347-55. PubMed ID: 21958878
    [Abstract] [Full Text] [Related]

  • 16. A homogeneous enzyme fragment complementation cyclic AMP screen for GPCR agonists.
    Golla R, Seethala R.
    J Biomol Screen; 2002 Dec 30; 7(6):515-25. PubMed ID: 14599349
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Development of a homogeneous calcium mobilization assay for high throughput screening of mas-related gene receptor agonists.
    Zhang R, Yan PK, Zhou CH, Liao JY, Wang MW.
    Acta Pharmacol Sin; 2007 Jan 30; 28(1):125-31. PubMed ID: 17184592
    [Abstract] [Full Text] [Related]

  • 19. A quantitative description of the activation and inhibition of CFTR by potentiators: Genistein.
    Moran O, Zegarra-Moran O.
    FEBS Lett; 2005 Jul 18; 579(18):3979-83. PubMed ID: 15996659
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.